Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Clin Cases. May 6, 2020; 8(9): 1608-1619
Published online May 6, 2020. doi: 10.12998/wjcc.v8.i9.1608
Table 2 Multivariate analysis of factors influencing survival using a Cox proportional hazards model
CharacteristicOverall survival
Recurrence-free survival
P valueHR95%CIP valueHR95%CI
Sex
Male1.0001.000
Female0.4340.9430.813-1.0930.2920.9250.801-1.069
Age
≤ 60 yr1.0001.000
> 60 yr0.0011.7231.502-1.9780.0011.6581.451-1.895
Tumour size
≤ 5 cm1.0001.000
> 5 cm0.0011.4551.252-1.6900.0011.5051.302-1.740
Lymphovascular invasion
No1.0001.000
Yes0.0011.6781.450-1.9430.0011.6761.455-1.931
Lymph node metastasis
No1.0001.000
Yes0.0470.8660.752-0.9980.1110.8940.780-1.026
Depth of invasion
Muscularis propria0.1020.6540.394-1.0880.1600.6960.419-1.155
Sub-serosal0.1250.6760.410-1.1150.2000.7210.437-1.189
Serosal exposed0.0800.6360.383-1.0550.1420.6850.413-1.135
Serosal invasion0.2870.7050.370-1.3420.2720.6970.366-1.189
Histology
Tubular adenocarcinoma (well)1.0001.000
Tubular adenocarcinoma (moderate)0.0361.7831.038-3.0610.0691.5620.967-2.523
Tubular adenocarcinoma (poorly)0.0082.0701.211-3.5380.0261.7161.067-2.759
Signet ring cell carcinoma0.0012.6891.535-4.7070.0012.2901.387-3.781
Mucinous adenocarcinoma0.1561.6010.836-3.0660.2361.4310.791-2.588